Related Experiment Video
Updated: Aug 10, 2025

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
PATHOLOGIC FINDINGS IN GENDER-AFFIRMING MASTECTOMY: A SYSTEMATIC REVIEW
1Division of Plastic and Reconstructive Surgery, Temple University Hospitals, Philadelphia, PA, USA.
Pathologic evaluation of breast tissue after gender-affirmation mastectomy (GAM) is common, but premalignant or malignant findings are rare (2.42% incidence). Standardized pathology methods are needed to guide future practice recommendations.
Area of Science:
- Oncology
- Pathology
- Gender-affirming care
Background:
- Gender-affirmation mastectomy (GAM) is increasingly sought by transgender individuals.
- Pathologic evaluation of post-GAM breast tissue is standard, but its utility is debated.
- Limited research exists on the incidence and types of breast lesions found in GAM specimens.
Approach:
- A systematic literature review following PRISMA guidelines was conducted.
- Medical publications on pathology reports following GAM were analyzed.
- The incidence of benign and malignant breast lesions was assessed.
Key Points:
- Eight studies comprising 1278 patients met inclusion criteria.
- The overall incidence of pre-malignant lesions was 2.42%.
- Specific pre-malignant findings included flat epithelial atypia, atypical hyperplasia, atypical ductal hyperplasia, atypical lobular hyperplasia, and lobular carcinoma in situ.
Conclusions:
- While premalignant or malignant findings are uncommon in GAM specimens, pathologic evaluation is prevalent.
- Inconsistent reporting of patient characteristics (age, hormonal therapy, family history) limits statistical analysis.
- Further research with standardized pathology methods is required to establish practice guidelines.
More Related Videos
05:05Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022